GEN Exclusives

More »

Market and Technology Analysis

More »
Dec 27, 2013

China’s In Vitro Diagnostics Marketplace, Part I

Although China has a vibrant domestic CLIA sector, the country’s MDx market is expanding rapidly and opportunities abound.

China’s In Vitro Diagnostics Marketplace, Part I

There are around 20,000 clinical labs in China, which roughly corresponds to the number of hospitals in the country. [Photo Credit: © Elena Kovaleva/]

  • This GEN Report Provides a Snapshot of the China In vitro Diagnostics Marketplace based on Primary Market Analysis

    • Infectious Disease Testing Contributes to the Bulk of this Space Currently—with Few Disease Classes Dominating Revenue Generation Today
    • The Field is Fragmented with Thousands of End-User Laboratories where Testing is Performed
    • Both Local as well as Multinational Companies are Active in this Marketplace
    • Oncology Testing Represents a Future Growth Opportunity for this Marketplace and Offers Entry Opportunity to Technology Providers to Establish Partnerships with Local Companies to Participate in this Growth

     Click here to download this PDF report

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »